TBI – Survivors, Caregivers, Family, and Friends

Posts tagged ‘David Figurski Professor Emeritus Columbia University’

New News: . . . . . . . ZOOM! Coffee with the Authors @ BIAAZ

New News: . . . . . . . . ZOOM! Coffee with the Authors @ BIAAZ

presented by

Donna O’Donnell Figurski

David & Donna Figurski

I’m so excited to be invited by the Brain Injury Alliance of Arizona (BIAAZ), to share my book with you. PRISONERS WITHOUT BARS: A CAREGIVER’S TALE has been called a compelling read, a true-to-life drama, and a heart-warming and inspiring love story. What do YOU call it?

More than fifteen years after my husband, David’s traumatic brain injury in January 2005, we are still searching for the light at the end of the tunnel. It’s there. It’s just still so tiny.

I hope you will join me on Saturday, October 24th at 10:30a Pacific Time for a virtual book club meeting on ZOOM.

It’s FREE! It’s FREE! It’s FREE! It’s FREE!

Please come hear me talk about my book and read a short excerpt.
Bring your QUESTIONS.

REGISTER HERE and you will receive a link to attend.

Can’t wait to see you there.

I’d love to hear what you think of PRISONERS WITHOUT BARS: A CAREGIVER’S TALE. Reviews on Amazon, Barnes and Noble, and Goodreads are really appreciated. Reviews keep books alive.

(Clip Art compliments of Bing.)

(Photos compliments of contributor.)

As I say after each post:

Please leave a comment by clicking the blue words “Leave a Comment” below this post.

anim0014-1_e0-1

Feel free to follow my blog. Click on “Follow” on the upper right sidebar.

If you like my blog, share it intact with your friends. It’s easy! Click the “Share” buttons below.

Read All About It! . . . . . . . Prisoners without Bars: A Caregiver’s Tale

Read All About It!

Prisoners without Bars: A Caregiver’s Tale

presented by

Donna O’Donnell Figurski – author

Donna & David with ARC of Prisoners without Bars: A Caregiver’s Tale

 

My memoir, Prisoners without Bars: A Caregiver’s Tale, is not only a story of David’s and my struggles after his traumatic brain injury, but it is also a love story. Though my memoir addresses a dire topic, it is peppered with comedic situations. They say laughter is the best medicine, and again, they are right.

Prisoners without Bars is a heart-wrenching memoir that will make you laugh, cry, and G-A-S-P. I promise!

 

Boy Laughing

 

Girl Crying girl-crying-clipart-34

Girl Gasping 2

It’s not a beach read, but it reads like one. It’s fast! It’s easy! It’s fascineasy. I mean fascinating.

What Readers are Saying!

Jackie said – “A beautiful and touching story.”

Anonymous Amazon Customer said – “I loved this book. almost couldn’t put it down.

jlgwriter said – “I found the story powerful and compelling.

Todd & Kim said – “This is such an inspirational story of survival! The book is a very easy read and informative as well as inspiring!!”

Judy said – “Donna O’Donnell Figurski tells her story of grace, love, frustration, anger, disappointment, strength, joy, and above all hope.”

Marge said – “I read it in one fell swoop… I guess the word that would describe your book, your life, and who you are is SUPERCALIFRAGILISTICEXPIALIDOCIOIUS.”

Anonymous said – “This book pulled me in immediately and didn’t let me go until the end! ”

Helen said – “Could not put this book down. Written for easy reading. It was like having a conversation with a friend.” “I finished it in one day with some teary moments along with some chuckles. A must read!!”

Get Your Copy Now

Read It!               Review It!

Click Links under Book

51R7Mht63EL._SX332_BO1,204,203,200_

PAPERBACK!        Read it Now!                              e-BOOK!      Read it Now!

 

Stay Safe and Healthy!

Clip Art compliments of Bing.)

(Photos compliments of contributor.)

As I say after each post:

Please leave a comment by clicking the blue words “Leave a Comment” below this post.

Feel free to follow my blog. Click on “Follow” on the upper right sidebar.anim0014-1_e0-1

If you like my blog, share it intact with your friends. It’s easy! Click the “Share” buttons below.

 

COVID-19 – It’s Everywhere . . Will an Early Vaccine for COVID-19 Be Safe?


Will an Early Vaccine for COVID-19 Be Safe?

by

Columbia University Professor Emeritus, Dr. David Figurski

presented by

Donna O’Donnell Figurski

(Disclaimer: The World Health Organization <WHO> has officially named the new coronavirus as SARS-CoV-2 and the disease it causes as COVID-19. Because the majority of people, including much of the press, commonly refer to the virus as “COVID-19,” to avoid confusion I use COVID-19 as the name of the virus in these posts.)

 

David Figurski

David H. Figurski, Ph.D & Survivor of Brain Injury

There is intense pressure from this Administration for any good news that might bolster its re-election chances. The government’s own FDA (Food and Drug Administration) might shorten the three required clinical trials that are key to proving the safety and efficacy of any vaccine before it’s approved for use by the public.

There is good reason to be concerned that government officials from this Administration might approve short-cuts to well-established scientific requirements because they want to speed things up. Both the FDA and the CDC (Centers for Disease Control & Prevention), two government agencies I have always trusted, have already bowed to political pressure from this Administration. The FDA approved hydroxychloroquine use for COVID-19 and later rescinded its approval when the drug was found to be ineffective against COVID-19 and to cause some dangerous side-effects in some people. The CDC, after feeling pressure from the Administration, revamped its back-to-school guidelines.

twiv-300x225

Dr. Vincent Racaniello – Columbia University virologist

Drs. Vincent Racaniello (virologist, Columbia U., host of the TWiV <This Week in Virology> podcasts), Brianne Barker (immunologist, Drew U.), and Rich Condit (retired virologist, Professor Emeritus, U. of Florida) discuss this issue in the TWiV podcast #631 of June 25, 2020. I urge you to listen to minutes 4:00-9:00. These three scientists talk about the importance of impartial and uncorrupted science in driving vaccine development and approval.

Also, an article about this issue can be found in the July 29, 2020, issue of HuffPost.

VaccineA legitimate way for the large Phase III clinical trial to end early is when the benefit is obvious. For example, if a vaccine candidate were given to 20,000 people and a placebo were given to another 20,000 people, the efficacy of the vaccine would be obvious (and statistically sound) if several hundred people in the placebo group became sick, while no person in the vaccine group became sick. Such an obvious result is exceedingly rare, and so, since it normally takes about eight months to do a Phase III clinical trial, if all goes well, we probably won’t have a confidence-inspiring vaccine until 2021.

Stay Safe and Healthy!

Clip Art compliments of Bing.)

(Photos compliments of contributor.)

As I say after each post:

Please leave a comment by clicking the blue words “Leave a Comment” below this post.

Feel free to follow my blog. Click on “Follow” on the upper right sidebar.anim0014-1_e0-1

If you like my blog, share it intact with your friends. It’s easy! Click the “Share” buttons below.

COVID-19 – It’s Everywhere . . . Interview with Dr. Anthony Fauci

Dr. Anthony Fauci – an interview by Drs. Vincent Racaniello and Rich Condit, virologists

by

Columbia University Professor Emeritus, Dr. David Figurski

presented by

Donna O’Donnell Figurski

 

(Disclaimer: The World Health Organization <WHO> has officially named the new coronavirus as SARS-CoV-2 and the disease it causes as COVID-19. Because the majority of people, including much of the press, commonly refer to the virus as “COVID-19,” to avoid confusion I use COVID-19 as the name of the virus in these posts.)

David H. Figurski, Ph.D & Survivor of Brain Injury

If you believe in science and facts, this 36-minute podcast will be a treat and essential listening. It was recorded on July 16, 2020, and posted on July 17. (Note: The link is for the page that has all the TWiV podcasts. Make sure you are listening to #641.)

Dr. Vincent Racaniello, a virologist, was my colleague in the Department of Microbiology & Immunology at Columbia University. He does a podcast on viruses called TWiV (This Week in Virology).

Dr. Vincent Racaniello – Columbia University virologist

Vincent, Rich Condit (a retired virologist from the University of Florida), and Dr. Fauci (Director of the National Institute of Allergy and Infectious Diseases) discuss COVID-19 and the pandemic. Among the topics discussed are the paths of infection, symptoms, testing, re-opening schools, fatality rate, immunity, and vaccines.

 

 

Normally, the TWiV scientists make their discussion understandable to non-scientists. But, these three scientists were working against a time-constraint, and they sometimes used terms that some of you may not be familiar with. To help you, I’ve made a glossary. The order of the terms in the list is based on the time in the podcast when the term is first used (noted in parentheses).

Dr. Anthony Fauci 071920

Director of the National Institute of Allergy and Infectious Diseases (NIAID)

Dr. Fauci was also interviewed for 64 minutes in 2013 by Vincent and Rich (TWiV #219).

 

Glossary provided by Dr. Figurski for easier listening.

glossary

PCR-able (2:52) – based on the PCR (polymerase chain reaction) test, which is a very sensitive test for the RNA chromosome (or a chromosomal RNA fragment) of the virus

fomite (3:11) – an infectious object or material

viral load (4:05) – the number of viruses

cycle threshold (4:27) – the PCR test is based on a number of amplification cycles to see a signal; the number of amplification cycles needed is related to the number viruses present; the higher the number of cycles needed, the lower the number of viruses present

nucleotides (5:05) – the building blocks for the viral RNA; the RNA chromosome of COVID-19 is made up of about 30,000 nucleotides

BSL-3 lab (5:12) – a bio-safety level 3 lab has containment and safety precautions that allow scientists to work with microbes thought to be dangerous

antigen (11:47) – a substance that stimulates the production of antibodies to itself; infection with COVID-19 leads to the body’s production of anti-COVID-19 antibodies; in the COVID-19 test discussed here, viral antigens (probably viral proteins) are used to bind to anti-COVID-19 antibodies to detect them; the presence of anti-COVID-19 antibodies is an indication that a person is now infected with COVID-19 or was infected in the past

systemic infection (13:21) – infection of other organs – not just infection of the lungs

systemic sequelae (13:23) – symptoms of infection in other organs

viremia (13:32) – the presence of virus in the blood; because the blood goes to all organs, a viremia allows the virus to reach other organs and can lead to a systemic infection

endothelium (14:22) – the layer of cells that lines organs and vessels

SARS (15:18) – the first SARS (Severe Acute Respiratory Syndrome) pandemic of 2003 – also caused by a coronavirus

MERS (15:21) – Middle East Respiratory Syndrome – another earlier and limited pandemic caused by a coronavirus

sero-prevalence (16:04) – the fraction of people in a population who are positive for antibodies to COVID-19; antibody positivity is an indication that a person is now infected with COVID-19 or was infected in the past

herd immunity (16:28) – immunity of the population by infection or by a vaccine; when people are infected (and recover if they have symptoms), they become immune; if enough people are immune, “herd immunity” has been achieved without a vaccine; the virus has few people to infect productively, and its spread slows to almost nothing; estimates are that 70-80% of the population must become immune to protect the population

Moderna vaccine (20:55) – the company Moderna teamed up with Dr. Fauci’s group and seems to be having some good success so far in phase I and phase II clinical trials (of three phases, see below); instead of the standard method of using a viral protein or several viral proteins to stimulate the production of neutralizing antibodies (see below), the Moderna vaccine uses a brand new technology based on the mRNA (see below) for the viral protein, a method that has never before been used to produce a vaccine

clinical trials – clinical development of a vaccine is a three-phase process. During Phase I, small groups of people receive the trial vaccine. In Phase II, the clinical study is expanded and the vaccine is given to people who have characteristics (such as age and physical health) similar to those for whom the new vaccine is intended. In Phase III, the vaccine is given to thousands of people and tested for efficacy and safety. (From the CDC)

mRNA (20:57) – messenger RNA; in cells, the genetic code for the production of proteins resides in the chromosomes, which are made of the nucleic acid DNA; that code is read and translated into the proteins (the machines of the cell) by the cell’s protein factories – the ribosomes; because the ribosomes need to get the code from the DNA, the messenger RNA (mRNA) comes into play; (RNA is a nucleic acid very closely related to DNA); a protein-machine copies the DNA’s code into mRNA, which then brings the code to the protein factory, where it is read and the protein is made

neutralizing antibody (21:09) – an antibody that blocks infection by the virus; for COVID-19, an antibody that inactivates the spike protein of the virus (see below) is a neutralizing antibody

convalescent serum (21:17) – serum from the blood of patients who have recovered from COVID-19; the serum contains the antibodies

spike protein (21:51) – a protein of COVID-19; important because it’s needed for the virus to bind tightly to the ACE2 (22:19) (angiotensin converting enzyme 2) protein that’s on the surface of lung cells; the binding is needed for the virus to gain entry to the cell and start the infection; a target for some vaccines; antibodies that inactivate the spike protein are called “neutralizing antibodies”

hemagglutinin, neuraminidase (22:39) – surface proteins of influenza virus needed for infection and for the release of progeny virus, respectively; antibodies to these proteins (usually to hemagglutinin) are the basis of the vaccine for influenza virus

monoclonal antibody (27:29) – the body’s collection of antibodies is produced by a population of B cells; each B cell produces one specific antibody; if a B cell can be cloned and cultured away from the population of B cells, then that culture will produce only that one specific antibody (for example, an anti-spike protein antibody), also called a “monoclonal antibody”

pathogen (28:17) – infectious agent (virus, bacterium, or parasite) that causes disease

NIAID (31:40) – National Institute of Allergy and Infectious Diseases; a part of the National Institutes of Health (NIH); the NIAID is headed by Dr. Fauci

 

Stay Safe and Healthy!

Clip Art compliments of Bing.)

(Photos compliments of contributor.)

As I say after each post:

Please leave a comment by clicking the blue words “Leave a Comment” below this post.

Feel free to follow my blog. Click on “Follow” on the upper right sidebar.anim0014-1_e0-1

If you like my blog, share it intact with your friends. It’s easy! Click the “Share” buttons below.

COVID-19 — It’s Everywhere . . . Breakthrough in Basic Research May Defeat COVID-19

Breakthrough in Basic Research May Defeat COVID-19

by

Columbia University Professor Emeritus, Dr. David Figurski

presented by

Donna O’Donnell Figurski

 

(Disclaimer: The World Health Organization <WHO> has officially named the new coronavirus as SARS-CoV-2 and the disease it causes as COVID-19. Because the majority of people, including much of the press, commonly refers to the virus as “COVID-19,” to avoid confusion I use COVID-19 as the name of the virus in these posts.)

David H. Figurski, Ph.D & Survivor of Brain Injury

 

Exciting results indicate that a novel idea might bring COVID-19 under control.  The new technology has been shown to work at the lab bench.  Now scientists are doing animal studies and, later, human studies.

Scientists at Boston University (BU) and the University of California at San Diego (UCSD) have made coated nanoparticles that are covered with pieces of lung cell membrane. (About 1000 tiny particles, or “nanoparticles,” can line up in the space equal to the width of a human hair.) The coated nanoparticles mimic the lung cells that normally bind the virus and allow an infection to start.  But, when the virus tries to infect a coated nanoparticle, the virus dies.  Essentially, the coated nanoparticle is a lethal decoy.

Research in the lab indicates that the new technology might be able to end the COVID-19 pandemic. Also, if the technology works in humans, coated nanoparticles will likely be important for inactivating other viruses and for dealing with future pandemics.

Specific nanoparticles can be made to mimic any cell that any virus infects.  So, coated nanoparticles can be made that are specific for any virus (for example, for influenza virus or for Ebola virus).  Also, once the cell normally infected by a previously unknown virus to start an infection has been identified (as it was for COVID-19), the relevant coated nanoparticles can be made. So, a novel virus can be inactivated even though little is known about the molecular details of its biology.

Scientists were surprised to learn that the coated nanoparticles for COVID-19 bind the SARS-2 coronavirus even better than the lung cells normally infected by the virus.  So, this approach for COVID-19 is likely be very efficient.

In COVID-19 infections, sometimes the immune response is too active and causes severe disease or death.  The dexamethasone breakthrough I wrote about earlier works by dampening the immune response.  The scientists surprisingly found that coating another batch of nanoparticles with membrane pieces from cells of the immune system also dampened the immune response.

The scientists envision a protective coated nanoparticle mixture for COVID-19 that has two types of coated nanoparticles (one that mimics the lung cells that are infected and another that dampens the immune response). The mixture would be simply administered as a nasal spray.

 

Stay Safe and Healthy!

Clip Art compliments of Bing.)

(Photos compliments of contributor.)

As I say after each post:

Please leave a comment by clicking the blue words “Leave a Comment” below this post.

Feel free to follow my blog. Click on “Follow” on the upper right sidebar.anim0014-1_e0-1

If you like my blog, share it intact with your friends. It’s easy! Click the “Share” buttons below.

 

COVID-19 — It’s Everywhere . . . Drug Breakthrough Significantly Prevents COVID-19 Deaths

Drug Breakthrough Significantly Prevents COVID-19 Deaths

by

Columbia University Professor Emeritus, Dr. David Figurski

presented by

Donna O’Donnell Figurski

 

(Disclaimer: The World Health Organization <WHO> has officially named the new coronavirus as SARS-CoV-2 and the disease it causes as COVID-19. Because the majority of people, including much of the press, commonly refer to the virus as “COVID-19,” to avoid confusion I use COVID-19 as the name of the virus in these posts.)

COVID-19

David H. Figurski, Ph.D & Survivor of Brain Injury

Research at the University of Oxford in England showed for the first time that a drug prevented a major fraction of deaths in severely sick patients with COVID-19.

Dexamethasone was found in a large clinical trial to cause a significant reduction in deaths. It can be prescribed as pills, and it is a common, readily available, and relatively inexpensive drug

A major problem after infection by COVID-19 is that the immune response of some individuals is too aggressive (often causing what’s called a “cytokine storm”) and can lead to death. Because dexamethasone is a steroid that dampens the immune response, the prediction was that it might help to prevent deaths by COVID-19.

The research showed that it does.

There are about 3 deaths for every 8 patients on ventilators.  Dexamethasone treatment reduced those deaths by one-third.  So, 1 death would be prevented for every 8 patients on ventilators.  About 5 deaths occur in every 25 patients on oxygen only. Dexamethasone treatment reduced those deaths by one-fifth, or about 1 less death for every 25 patients on oxygen only. Dexamethasone treatment had no effect on patients not on ventilators or receiving oxygen only.

Given that a major fraction of the over 118,000 deaths in the US so far (at 6:00 pm ET on June 18, 2020) were on ventilators or oxygen only, dexamethasone treatment is predicted to prevent many deaths.

The UK’s Chief Scientific Adviser, Sir Patrick Vallance, said: “This is a ground-breaking development in our fight against the disease, and the speed at which researchers have progressed finding an effective treatment is truly remarkable.”

 

Stay Safe and Healthy!

Clip Art compliments of Bing.)

(Photos compliments of contributor.)

As I say after each post:

Please leave a comment by clicking the blue words “Leave a Comment” below this post.

Feel free to follow my blog. Click on “Follow” on the upper right sidebar.anim0014-1_e0-1

If you like my blog, share it intact with your friends. It’s easy! Click the “Share” buttons below.

 

COVID-19 — It’s Everywhere . . . Vaccine is Possible

COVID-19 . . . Evidence that a Vaccine is Possible

by

Columbia University Professor Emeritus, Dr. David Figurski

presented by

Donna O’Donnell Figurski

 

(Disclaimer: The World Health Organization <WHO> has officially named the new coronavirus as SARS-CoV-2 and the disease it causes as COVID-19.  Because the majority of people, including much of the press, commonly refer to the virus as “COVID-19,” to avoid confusion, I use COVID-19 as the name of the virus in these posts.)

COVID-19

The 100+ labs trying to develop a vaccine for COVID-19 were delighted with a study showing that COVID-19 stimulates a strong antibody response in humans. Scientists from the University of California at San Diego (UCSD) demonstrated that a vaccine for COVID-19 is definitely possible.

The scientists studied blood from mildly sick individuals who recovered. They found a high level of antibodies to the spike protein, used by COVID-19 to infect.

The strong antibody response suggests that immunity will occur in humans and will last a while, but no one knows for how long – weeks? months? years?

The scientists were surprised by another result. For you also to understand it, I have to give you some background. (Sorry!)

There are seven coronaviruses that infect humans.

Four are common and cause mild, cold-like symptoms.  We’ve all probably had one or more of these.

Three coronaviruses (SARS-CoV, SARS-CoV-2 <which causes COVID-19>, and MERS- CoV) cause serious human disease and some fatalities.

Blood taken before COVID-19 even existed in humans nevertheless showed the presence of antibodies that reacted with COVID-19.  Infection with one of the mild coronaviruses may have stimulated the body’s production of some antibodies that cross-react with COVID-19.

Some seemingly healthy individuals have died from COVID-19. In contrast, some people not predicted to do well had mild disease or were asymptomatic. Doctors are perplexed by their inability to predict who will recover.

David H. Figurski, Ph.D & Survivor of Brain Injury

One possibility is that the amount of cross-reactive antibodies arising from previous infection with one or more of the mild coronaviruses may determine how well a COVID-19-infected person will do.

 

Stay Safe and Healthy!

 

Clip Art compliments of Bing.)

(Photos compliments of contributor.)

As I say after each post:

Please leave a comment by clicking the blue words “Leave a Comment” below this post.

Feel free to follow my blog. Click on “Follow” on the upper right sidebar.anim0014-1_e0-1

If you like my blog, share it intact with your friends. It’s easy! Click the “Share” buttons below.

COVID-19 — It’s Everywhere . . . To Open or Not to Open

COVID-19 . . . To Open or Not to Open

by

Columbia University Professor Emeritus, Dr. David Figurski

presented by

Donna O’Donnell Figurski

 

(Disclaimer: The World Health Organization <WHO> has officially named the new coronavirus as SARS-CoV-2 and the disease it causes as COVID-19.  Because the majority of people, including much of the press, commonly refer to the virus as “COVID-19,” to avoid confusion, I use COVID-19 as the name of the virus in these posts.)

COVID-19

David H. Figurski, PhD — Brain Injury Survivor — Professor Emeritus of Microbiology & Immunology — Columbia University

 

Some governors say “Open.” Scientists say “Don’t open.” Whom do you believe?

I’m a scientist.  I know where I stand.

Below are some facts to help you decide.

For those of you in the west, the coronavirus infections have just begun.  You can see from the map of May 19 (see below) that infections are still moving westward.

Coronavirus Map – New York Times – 05/19/20

Many people, particularly those in the west, don’t seem to understand that the US is still in the early stages of this pandemic. They are lulled by the low number of cases in their state. The numbers are misleading for two reasons.

(1) Only seriously symptomatic (mostly hospitalized) people and celebrities are being tested because the US is seriously in need of more testing.  (2) The virus has not reached you yet. (That’s the especially true in the western half of the US.)

New York City is still very bad, but strict social-distancing guidelines have produced a significant drop in new cases.

Washington State had the potential to become a major hot spot, but they acted quickly and aggressively.

In contrast, several states are opening up and relaxing guidelines, despite a continued rise in new cases.  (That’s the case here in Arizona, where Governor Ducey allowed restaurants to open this week. This decision is particularly horrifying because the pandemic hasn’t really reached us yet.)

Reported cases in the United States

(Every red dot represents a cluster of infections – probably started by an infected asymptomatic traveler.  Right now, most cases are in the east, but every day you see more red dots in the western half of the US.)

 

David H. Figurski, Ph.D & Survivor of Brain Injury

Stay Safe and Healthy!

 

Clip Art compliments of Bing.)

(Photos compliments of contributor.)

As I say after each post:

Please leave a comment by clicking the blue words “Leave a Comment” below this post.

Feel free to follow my blog. Click on “Follow” on the upper right sidebar.anim0014-1_e0-1

If you like my blog, share it intact with your friends. It’s easy! Click the “Share” buttons below.

COVID-19 . . . It’s Everywhere! Columbia University Professor Emeritus, Dr. David Figurski Talks about Coronavirus

COVID-19 . . . It’s Everywhere!

Columbia University Professor Emeritus, Dr. David Figurski

Talks about Coronavirus

by David Figurski, Ph.D

presented by

Donna O’Donnell Figurski

 

(Disclaimer: The World Health Organization <WHO> has officially named the new coronavirus as SARS-CoV-2 and the disease it causes as COVID-19.  Because the majority of people, including much of the press, commonly refer to the virus as “COVID-19,” to avoid confusion, I use COVID-19 as the name of the virus in these posts.)

COVID-19

David Columbia Award May 2017Because the COVID-19 pandemic has affected everyone, including the brain injury community, I have added a new category called “COVID-19” to this blog. This category is for posting much-needed information and facts on the new coronavirus and the global pandemic it has caused.

The major reason I added the COVID-19 category is that I have unique access to a survivor of brain injury who is knowledgeable about this pandemic.

For 35 years, my husband, David, was a professor and did research in the Department of Microbiology & Immunology at Columbia University. He retired on September 1, 2013. In January 2005, David had a cerebellar hemorrhage. He survived a three-week

coronavirus-covid-19-design-vector

coma and three brain surgeries in the first two weeks of his coma. Unfortunately, he was left with many physical disabilities, but his cognitive brain was untouched, allowing him to return full-time to the faculty after 19 months. (Those 19 months are described in detail in my book Prisoners without Bars: A Caregiver’s Tale.) For 45 years, David did research on the molecular genetics of various microorganisms, including viruses.

02 Fork Yield Banner copyTo allow you to be introduced to David, I am reposting the link to my radio show of April 19, 2020, on the Brain Injury Radio Network called,  “Another Fork in the Road: BI Survivor/Columbia Prof Dr. David Figurski & Covid19.” (The link first appeared in my post on May 4, 2020.) David was my guest, and I interviewed him about his brain injury and about COVID-19. (Our discussion of COVID-19 begins at 49:50.)

David Figurski

David H. Figurski, Ph.D & Survivor of Brain Injury

Clip Art compliments of Bing.)

(Photos compliments of contributor.)

As I say after each post:

Please leave a comment by clicking the blue words “Leave a Comment” below this post.

Feel free to follow my blog. Click on “Follow” on the upper right sidebar.anim0014-1_e0-1

If you like my blog, share it intact with your friends. It’s easy! Click the “Share” buttons below.

 

On the Air: . . . . . . . . . . . . . . . Guest: Dr. David Figurski

On the Air: Guest: Dr. David Figurski

presented by

Donna O’Donnell Figurski

David Figurski

David H. Figurski, Ph.D & Survivor of Brain Injury

 

Dr. David Figurski, retired professor of microbiology, talks about his brain injury and COVID-19

I don’t often publicize my radio show on the Brain Injury Radio Network, but one of our brain injury survivors is knowledgeable about the COVID-19 pandemic, which I’m sure is on your mind.  Like me, you probably have lots of questions.

My guest on the April 19th show was my husband, Dr. David Figurski.  David has been living with several physical disabilities since January 2005, when he had a brain hemorrhage, but, fortunately, after three brain surgeries in two weeks, he was unaffected cognitively.  For 35 years, including eight years after his traumatic brain injury, David was a professor in the Department of Microbiology & Immunology at Columbia University, where he also had a research lab.  David has done research on bacteria and viruses for 45 years.  Unsurprisingly, he has been very interested in the new human coronavirus and the global pandemic it has caused.news-clipart-news-anchor-4

My 80-minute show was live on April 19th, but it was recorded and can now be listened to at any time as a podcast.  My interview of David has two parts.  From 9:30 to 49:50, David and I talk about life with his brain injury.  From 49:50 to the end, David and I discuss the COVID-19 pandemic.

To Listen Go To:

SPEAK OUT! On the Air with . . . Brain Injury Radio Show Menu “Another Fork in the Road”

blogtalkradio.com/braininjuryradio/2020/04/20/another-fork-in-the-road-bi-survivorcolumbia-prof-dr-david-figurski-covid19

 

(Clip Art compliments of Bing.)

(Photos compliments of guests.)

As I say after each post: Please leave a comment by clicking the blue words “Leave a Commentanim0014-1_e0-1 below this post.

Feel free to follow my blog. Click on “Follow” on the upper right sidebar.

If you like my blog, share it intact with your friends. It’s easy! Click the “Share” buttons below.

If you don’t like my blog, “Share” it intact with your enemies. I don’t care!

Feel free to “Like” my post.

Tag Cloud

How Life Has Happened For Me

Grow Through What You Go Through

Claire Stibbe

Thriller Author and Blogger at Bookpreneur

Fat Cow Co

New Age Blogger

The Care Factor

Loving someone with a Traumatic Brain Injury

Brain Injury Blog With Free TBI Information

Brain Injury Blog and Helpful Articles

Montclair Write Group

Writing Support Group

Brain Injury Support Group of Duluth-Extension

Brain Injury Information and SUPPORT

Women Worldwide Network

Women around the world share their incredible stories

Brain Aneurysm Global Insight

Brain Aneurysm, cerebral hemorrhaging, hemorrhage stroke

Motivational Coping & Healing

Rising Above the Hardships

catherinelanser.wordpress.com/

Creative Nonfiction, Memoir, and the Brain

Wrath of Violets

A retrospective documentary of my most inner thoughts: A success in the making

Karen DeBonis

Memoir and creative nonfiction

Surviving TBI

Learning how to survive with spouse's TBI

BQB Publishing

Tomorrow's Best Sellers Today

Knit Neutrality

Knit (Verb) | 'nit : to join together

%d bloggers like this: